NASDAQ:BNR Burning Rock Biotech (BNR) Stock Price, News & Analysis $17.63 -0.97 (-5.22%) Closing price 04:00 PM EasternExtended Trading$17.55 -0.08 (-0.48%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Burning Rock Biotech Stock (NASDAQ:BNR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Burning Rock Biotech alerts:Sign Up Key Stats Today's Range$17.30▼$18.6050-Day Range$8.79▼$18.6052-Week Range$6.79▼$41.72Volume86,327 shsAverage Volume27,438 shsMarket Capitalization$185.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Burning Rock Biotech Limited is a biotechnology company focused on precision oncology. The company develops and commercializes next-generation sequencing (NGS)-based tests designed to support cancer screening, diagnosis, treatment selection and disease monitoring. Its products and services include tumor profiling and liquid biopsy tests that analyze genetic changes associated with cancer. Burning Rock also provides testing services to hospitals, physicians and biopharmaceutical companies, including services intended to help identify patients for clinical trials and evaluate targeted cancer therapies. Founded in 2014, Burning Rock is headquartered in Guangzhou, China, and primarily serves the Chinese healthcare and pharmaceutical markets, with additional activities connected to international clinical development. The company was listed on the Nasdaq Global Select Market in 2020. Burning Rock was founded and is led by Yusheng Huang, who serves as chief executive officer.AI Generated. May Contain Errors. Read More Burning Rock Biotech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreBNR MarketRank™: Burning Rock Biotech scored higher than 11% of companies evaluated by MarketBeat, and ranked 866th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBurning Rock Biotech has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBurning Rock Biotech has only been the subject of 1 research reports in the past 90 days.Read more about Burning Rock Biotech's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Burning Rock Biotech is -20.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Burning Rock Biotech is -20.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBurning Rock Biotech has a P/B Ratio of 2.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Burning Rock Biotech's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.54% of the float of Burning Rock Biotech has been sold short.Short Interest Ratio / Days to CoverBurning Rock Biotech has a short interest ratio ("days to cover") of 0.44, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Burning Rock Biotech has recently increased by 3.24%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBurning Rock Biotech does not currently pay a dividend.Dividend GrowthBurning Rock Biotech does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.96 News SentimentBurning Rock Biotech has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Burning Rock Biotech this week, compared to 1 article on an average week. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Burning Rock Biotech insiders have not sold or bought any company stock.Percentage Held by Insiders30.30% of the stock of Burning Rock Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions30.03% of the stock of Burning Rock Biotech is held by institutions.Read more about Burning Rock Biotech's insider trading history. Receive BNR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Burning Rock Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNR Stock News HeadlinesOnconetix (NASDAQ:ONCO) & Burning Rock Biotech (NASDAQ:BNR) Financial ComparisonSeptember 27 at 5:44 AM | americanbankingnews.comBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25 at 12:00 AM | gurufocus.comAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly 80% afterward. He also called the housing crisis and the collapse of Bear Stearns and Lehman Brothers before they happened. Now Tilson says the day after this year's midterm elections, America enters a period of economic change unlike anything seen in decades - and most investors are unprepared.September 28 at 1:00 AM | Stansberry Research (Ad)Burning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comBurning Rock Biotech Limited: Burning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | finanznachrichten.deBurning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | globenewswire.comBurning Rock Biotech Corporate Event Calendar | NASDAQ:BNRJuly 10, 2026 | benzinga.comBurning Rock Announces Founder's Purchase of Its ADSsJuly 2, 2026 | globenewswire.comSee More Headlines BNR Stock Analysis - Frequently Asked Questions How have BNR shares performed this year? Burning Rock Biotech's stock was trading at $20.15 at the beginning of 2026. Since then, BNR stock has decreased by 12.5% and is now trading at $17.63. How were Burning Rock Biotech's earnings last quarter? Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) posted its earnings results on Thursday, September, 10th. The company reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($2.29) by $2.09. The firm had revenue of $19.84 million for the quarter, compared to analyst estimates of $19.21 million. Burning Rock Biotech had a negative net margin of 13.60% and a negative trailing twelve-month return on equity of 12.98%. When did Burning Rock Biotech's stock split? Shares of Burning Rock Biotech reverse split before market open on Wednesday, May 15th 2024.The 1-10 reverse split was announced on Wednesday, May 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Burning Rock Biotech IPO? Burning Rock Biotech (BNR) raised $196 million in an IPO on Friday, June 12th 2020. The company issued 13,500,000 shares at a price of $13.50-$15.50 per share. Morgan Stanley, BofA Securities and Cowen served as the underwriters for the IPO and CMBI and Tiger Brokers were co-managers. How do I buy shares of Burning Rock Biotech? Shares of BNR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Burning Rock Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Burning Rock Biotech investors own include Tesla (TSLA), NVIDIA (NVDA), Intel (INTC), Vertex Pharmaceuticals (VRTX), HubSpot (HUBS), NIO (NIO) and Alibaba Group (BABA). Company Calendar Last Earnings9/10/2026Today9/28/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 11 days, BNR's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:BNR CIK1792267 Webwww.brbiotech.com Phone86-185-0164-1666FaxN/AEmployees667Year Founded2014Profitability EPS (Trailing Twelve Months)($0.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.92 million Net Margins-13.60% Pretax Margin-13.48% Return on Equity-12.98% Return on Assets-8.59% Debt Debt-to-Equity RatioN/A Current Ratio3.05 Quick Ratio2.90 Sales & Book Value Annual Sales$77.16 million Price / Sales2.40 Cash FlowN/A Price / Cash FlowN/A Book Value$7.28 per share Price / Book2.42Miscellaneous Outstanding Shares10,520,000Free Float7,331,000Market Cap$185.47 million OptionableNot Optionable Beta1.38 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:BNR) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
